Obese persons with excess visceral fat have increased risk of diabetes
by Bruce Sylvester – Obese persons with excess visceral fat appear to be at an increased risk of developing Type 2 diabetes,
by Bruce Sylvester – Obese persons with excess visceral fat appear to be at an increased risk of developing Type 2 diabetes,
by Gary Finnegan – World Health Matters (Sweden) – Breast cancer screening has limited or no impact on breast cancer mortality among women aged 40-69, according to a… read more.
by Maria Dalby – Introduction – In many ways waiting lists to receive an organ transplantation look very much the same today as they did a decade ago… read more.
Prostate cancer is one of the most common cancers in men and early treatment is usually very successful. However, like other cancers, obesity increases the risk of aggressive… read more.
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer
by Bruce Sylvester – Normal weight persons with weight concentrated in their belly run a higher death risk of CVD-related death than obese-only individuals, researchers reported at ESC.
by Zara Qadir – BMI still offers a simple numeric measure of a person’s “thickness” or “thinness”. However, normal weight individuals who carry weight concentrated in their belly… read more.
by Bruce Sylvester – Obese persons who are metabolically healthy and fit have no more risk of developing or dying from cardiovascular disease or cancer than persons of… read more.
by Bruce Sylvester – The combination of obesity and low vitamin D deficiency appears to cause a greater risk of insulin resistance than either factor alone, researchers reported… read more.
by Gary Finnegan – World Health Matters (China) – Child diabetes levels in China are higher than those in the US, according to a startling new study based… read more.
by Bruce Sylvester – Two studies presented at EASL suggest the real human and economic costs of liver disease across Europe.
by Bruce Sylvester – Combination metformin and rosiglitazone is more effective than metformin monotherapy in youth with recent-onset type 2 diabetes,